Skip to contentSkip to Braille Studio

Library / Laws / 119th Congress / Senate Bills / S. 2665

S. 2665

To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical drugs of increased demand, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2025-08-016.0K⠃⠗⠋